Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS”
2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10358439
DNA binding agents with a minor groove binding tail
granted -
US 10358501
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
granted -
US 10357464
Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
granted -
US 10351522
Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof
granted -
US 10342771
Creatine oral supplementation using creatine hydrochloride salt
granted -
US 10342822
Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
granted -
US 10344025
GLS1 inhibitors for treating disease
granted -
US 10345310
Diagnostic test for early stage cancer
granted -
US 10335470
Immunogenic compositions comprising progastrin and uses thereof
granted -
US 10336786
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
granted -
US 10335382
Use of hydrogen sulfide synthesis inhibitors for cancer therapy
granted -
US 10335476
Vaccine to protect against Ehrlichia infection
granted -
US 10330600
Plasmonic-magnetic bifunctional nanotubes for biological applications
granted -
US 10329353
Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating tumor cells
granted -
US 10329326
Melanocortin 1 receptor ligands and methods of use
granted -
US 10328040
Therapeutic methods
granted -
US 10328139
Live-attenuated vaccine against plague
granted -
US 10322113
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same
granted -
US 10323070
VMP-like sequences of pathogenic Borrelia species and strains
granted -
US 10322069
Restorative resin compositions and methods of use
granted -
US 10322171
Vaccine with reduced enhancement of viral infection
granted -
US 10316073
FCRN antagonists and methods of use
granted -
US 10314860
Compositions and methods for treating and preventing venom related poisoning
granted -
US 10314950
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
granted